These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 20238314

  • 1. Dornase alfa for cystic fibrosis.
    Jones AP, Wallis C.
    Cochrane Database Syst Rev; 2010 Mar 17; (3):CD001127. PubMed ID: 20238314
    [Abstract] [Full Text] [Related]

  • 2. Dornase alfa for cystic fibrosis.
    Yang C, Chilvers M, Montgomery M, Nolan SJ.
    Cochrane Database Syst Rev; 2016 Apr 04; 4():CD001127. PubMed ID: 27043279
    [Abstract] [Full Text] [Related]

  • 3. Dornase alfa for cystic fibrosis.
    Yang C, Montgomery M.
    Cochrane Database Syst Rev; 2021 Mar 18; 3(3):CD001127. PubMed ID: 33735508
    [Abstract] [Full Text] [Related]

  • 4. Dornase alfa for cystic fibrosis.
    Yang C, Montgomery M.
    Cochrane Database Syst Rev; 2018 Sep 06; 9(9):CD001127. PubMed ID: 30187450
    [Abstract] [Full Text] [Related]

  • 5. Recombinant human deoxyribonuclease for cystic fibrosis.
    Jones AP, Wallis CE.
    Cochrane Database Syst Rev; 2003 Sep 06; (3):CD001127. PubMed ID: 12917899
    [Abstract] [Full Text] [Related]

  • 6. Inhaled mannitol for cystic fibrosis.
    Nolan SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2015 Oct 09; (10):CD008649. PubMed ID: 26451533
    [Abstract] [Full Text] [Related]

  • 7. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2020 May 01; 5(5):CD008649. PubMed ID: 32358807
    [Abstract] [Full Text] [Related]

  • 8. Inhaled mannitol for cystic fibrosis.
    Nevitt SJ, Thornton J, Murray CS, Dwyer T.
    Cochrane Database Syst Rev; 2018 Feb 09; 2(2):CD008649. PubMed ID: 29424930
    [Abstract] [Full Text] [Related]

  • 9. Deoxyribonuclease for cystic fibrosis.
    Kearney CE, Wallis CE.
    Cochrane Database Syst Rev; 2000 Feb 09; (2):CD001127. PubMed ID: 10796748
    [Abstract] [Full Text] [Related]

  • 10. Nebulised hypertonic saline for cystic fibrosis.
    Wark P, McDonald VM.
    Cochrane Database Syst Rev; 2018 Sep 27; 9(9):CD001506. PubMed ID: 30260472
    [Abstract] [Full Text] [Related]

  • 11. Nebulised hypertonic saline for cystic fibrosis.
    Wark P, McDonald VM, Smith S.
    Cochrane Database Syst Rev; 2023 Jun 14; 6(6):CD001506. PubMed ID: 37319354
    [Abstract] [Full Text] [Related]

  • 12. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R, Elkins M.
    Cochrane Database Syst Rev; 2011 May 11; (5):CD007923. PubMed ID: 21563162
    [Abstract] [Full Text] [Related]

  • 13. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R, Elkins M.
    Cochrane Database Syst Rev; 2016 Jul 26; 7(7):CD007923. PubMed ID: 27457496
    [Abstract] [Full Text] [Related]

  • 14. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME.
    Am J Respir Crit Care Med; 1995 Mar 26; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [Abstract] [Full Text] [Related]

  • 15. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R, Elkins M.
    Cochrane Database Syst Rev; 2013 Jun 05; (6):CD007923. PubMed ID: 23737088
    [Abstract] [Full Text] [Related]

  • 16. Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials.
    Mayer-Hamblett N, Ratjen F, Russell R, Donaldson SH, Riekert KA, Sawicki GS, Odem-Davis K, Young JK, Rosenbluth D, Taylor-Cousar JL, Goss CH, Retsch-Bogart G, Clancy JP, Genatossio A, O'Sullivan BP, Berlinski A, Millard SL, Omlor G, Wyatt CA, Moffett K, Nichols DP, Gifford AH, SIMPLIFY Study Group.
    Lancet Respir Med; 2023 Apr 05; 11(4):329-340. PubMed ID: 36343646
    [Abstract] [Full Text] [Related]

  • 17. Nebulised hypertonic saline for cystic fibrosis.
    Wark PA, McDonald V.
    Cochrane Database Syst Rev; 2000 Apr 05; (2):CD001506. PubMed ID: 10796798
    [Abstract] [Full Text] [Related]

  • 18. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM, Tiddens HA, Sy JP, McKenzie SG, Montgomery MD, Robinson PJ, Wohl ME, Konstan MW, Pulmozyme Early Intervention Trial Study Group.
    J Pediatr; 2001 Dec 05; 139(6):813-20. PubMed ID: 11743506
    [Abstract] [Full Text] [Related]

  • 19. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R, Elkins M.
    Cochrane Database Syst Rev; 2021 Mar 09; 3(3):CD007923. PubMed ID: 33686652
    [Abstract] [Full Text] [Related]

  • 20. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R, Elkins M.
    Cochrane Database Syst Rev; 2018 Nov 12; 11(11):CD007923. PubMed ID: 30480755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.